Elizabeth Hohmann

Elizabeth Hohmann established the OpenBiome and MGH donor stool banking programs that provide standardized FMT material for clinical trials including cancer immunotherapy microbiome modulation studies. Her clinical protocols for FMT administration have been adopted as standard procedures across oncology microbiome trials. Her work on microbiome transplant safety monitoring has established the pharmacovigilance framework necessary for regulatory approval of FMT-based cancer therapies.